101 related articles for article (PubMed ID: 4134221)
1. Editorial: The obliging wart.
Lancet; 1974 Jun; 1(7869):1267-8. PubMed ID: 4134221
[No Abstract] [Full Text] [Related]
2. Study of regressing warts by immunofluorescence.
Matthews RS; Shirodaria PV
Lancet; 1973 Mar; 1(7805):689-91. PubMed ID: 4120490
[No Abstract] [Full Text] [Related]
3. Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.
Lee AK; Eisinger M
Clin Exp Immunol; 1976 Dec; 26(3):419-24. PubMed ID: 188577
[TBL] [Abstract][Full Text] [Related]
4. Warts--a clinical's view.
Rees RB
Cutis; 1981 Aug; 28(2):175-80. PubMed ID: 6269806
[TBL] [Abstract][Full Text] [Related]
5. Human papova (wart) virus.
Rowson KE; Mahy BW
Bacteriol Rev; 1967 Jun; 31(2):110-31. PubMed ID: 5342713
[No Abstract] [Full Text] [Related]
6. Demonstration of human papovavirus in wart tissue by electrophoresis.
Steward EE; Mack WN; Foy RB
Lab Invest; 1968 Jul; 19(1):40-4. PubMed ID: 5671350
[No Abstract] [Full Text] [Related]
7. Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests.
Almeida JD; Goffe AP
Lancet; 1965 Dec; 2(7424):1205-7. PubMed ID: 4158822
[No Abstract] [Full Text] [Related]
8. Wart-virus antibodies and the prognosis of wart disease.
Pyrhönen S; Penttinen K
Lancet; 1972 Dec; 2(7791):1330-2. PubMed ID: 4118204
[No Abstract] [Full Text] [Related]
9. Primary tissue culture of human wart-derived epidermal cells (keratinocytes).
Niimura M; Pass F; Wooley R; Soutor CA
J Natl Cancer Inst; 1975 Mar; 54(3):563-9. PubMed ID: 164558
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity in wart infection.
Thivolet J; Viac J; Staquet MJ
Int J Dermatol; 1982 Mar; 21(2):94-8. PubMed ID: 6279530
[TBL] [Abstract][Full Text] [Related]
11. Verrucae: virus structure, localization of antigens, and comparison with the Shope papilloma.
Noyes WF
Cancer Res; 1968 Jul; 28(7):1321-4. PubMed ID: 4299002
[No Abstract] [Full Text] [Related]
12. Epidemiology of butchers' warts.
Jabłońska S; Obalek S; Gołebiowska A; Favre M; Orth G
Arch Dermatol Res; 1988; 280 Suppl():S24-8. PubMed ID: 2841908
[TBL] [Abstract][Full Text] [Related]
13. Concepts of wart regression.
Bender ME
Arch Dermatol; 1986 Jun; 122(6):644-7. PubMed ID: 3013101
[No Abstract] [Full Text] [Related]
14. Regression of flat warts and common warts.
Tagami H; Aiba S; Rokugo M
Clin Dermatol; 1985; 3(4):170-8. PubMed ID: 2850856
[No Abstract] [Full Text] [Related]
15. Warts. Biology and current therapy.
Pass F
Minn Med; 1974 Oct; 57(10):844-7, 852. PubMed ID: 4138814
[No Abstract] [Full Text] [Related]
16. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
Haftek M; Jabłonska S; Orth G
Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
[TBL] [Abstract][Full Text] [Related]
17. In vitro assay of immunity to human wart antigen.
Morison WL
Br J Dermatol; 1975 Nov; 93(5):545-52. PubMed ID: 1203178
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity to human papillomavirus.
Chardonnet Y; Viac J; Staquet MJ; Thivolet J
Clin Dermatol; 1985; 3(4):156-64. PubMed ID: 2850854
[No Abstract] [Full Text] [Related]
19. Antigenic relationships between polypeptides derived from plantar and hand wart viruses.
Staquet MJ; Viac J; Thivolet J
J Gen Virol; 1979 Jun; 43(3):713-7. PubMed ID: 90120
[TBL] [Abstract][Full Text] [Related]
20. Viral verruca, human papova virus infection. Epidermodysplasia verruciformis, vacuolar degeneration of the epidermis.
Cornelius CE; Witkowski JA; Wood MG
Arch Dermatol; 1968 Oct; 98(4):377-84. PubMed ID: 5676690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
